To evaluate if intermittent preventive treatment in infants (IPTi) consisting of SP
[Fansidar] given through the EPI scheme alongside routine immunisations at 3, 4 and 9 months
of age reduces de incidence of clinical malaria up to 12 months of age
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Hospital Clinic of Barcelona
Treatments:
Fanasil, pyrimethamine drug combination Pyrimethamine Sulfadoxine